Abstracts Archive - Page 968 of 2425 - ACR Meeting Abstracts

Abstract Number: 205 • 2019 ACR/ARP Annual Meeting
Does a Mandatory Non-medical Switch from Originator to Biosimilar Etanercept Lead to Increase in Healthcare Use and Costs? A Danish Register-based Study of 1620 Patients with Inflammatory Arthritis
Bente Glintborg ¹, Rikke Ibsen ², Rebekka Elisabeth Qwist Bilbo ³, Merete Lund Hetland¹ and Jakob Kjellberg ³, ¹DANBIO and Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Centre of Head and Orthopaedics, Rigshospitalet, Copenhagen, Denmark, ²i2minds, Aarhus, Denmark, ³VIVE, The Danish Centre for Social Science Research, Copenhagen, Denmark
Background/Purpose: Marketing of cheaper biosimilar biological agents has created financial incentives for switching from the corresponding originator drugs (=non-medical switch). The economic benefit might potentially…
Abstract Number: 206 • 2019 ACR/ARP Annual Meeting
Efficacy of Etanercept on Radiographic Progression in Adult Patients with Rheumatoid Arthritis or Psoriatic Arthritis: Final Results from a German Non-Interventional, Prospective, Multi-Center Study
Siegfried Wassenberg¹, Thilo Klopsch ², Anja Plenske ³, Silke Behnck-Knoblau ⁴, Jürgen Jobst ⁴, Pascal Klaus ⁴, Thomas Meng ⁴, Peter-Andreas Löschmann ⁴ and Rolf Rau ⁵, ¹Centre of Rheumatology, Ratingen, Germany, ²Internal Medicine Practice, Neubrandenburg, Germany, ³Pfizer Pharma GmbH, Berlin, Germany, ⁴Pfizer Pharma GmbH, Berlin, Berlin, Germany, ⁵Dusseldorf, Dusseldorf, Germany
Background/Purpose: Clinical trials showed that Etanercept (ETN) is highly effective in reducing clinical disease activity and often leading to remission and radiographic non-progression in patients…
Abstract Number: 207 • 2019 ACR/ARP Annual Meeting
Effects of Successive Switches to Different Biosimilars Infliximab on Immunogenicity in Chronic Inflammatory Diseases in Daily Clinical Practice
Ambre Lauret ¹, Anna Moltó ¹, Vered Abitbol ², Loriane Guterlann ³, Ornella Conort ³, Francois Chast ³, Claire Goulvestre ⁴, Claire Le Jeunne ⁵, Stanislas Chaussade ², Christian Roux ¹, Frédéric Batteux ⁶, Maxime Dougados ⁷, Yannick Allanore ¹ and Jerome Avouac¹, ¹Paris Descartes University, Cochin Hospital, Rheumatology department, Paris, France, ²Paris Descartes University, Cochin Hospital, Gastroenterology department, Paris, France, ³Paris Descartes University, Cochin Hospital, Department of Pharmacy, paris, France, ⁴Paris Descartes University, Cochin Hospital, Immunology Laboratory, Paris, France, ⁵Paris Descartes University, Cochin Hospital, Internal Medicine department, Paris, France, ⁶Paris Descartes University, Cochin Hospital, Immunology Laborator, Paris, France, ⁷Cochin Hospital, Paris, France
Background/Purpose: To determine whether the successive switches from innovator infliximab to a first then a second biosimilar infliximab, or from a first to a second…
Abstract Number: 208 • 2019 ACR/ARP Annual Meeting
Self-Reported Sleep Disturbances in Rheumatoid Arthritis (RA)
Patricia Katz¹, Sofia Pedro ² and Kaleb Michaud ³, ¹University of California, San Francisco, san francisco, CA, ²FORWARD, The National Databank for Rheumatic Diseases, Wichita, KS, ³FORWARD, The National Databank for Rheumatic Diseases and University of Nebraska Medical Center, Wichita, KS
Background/Purpose: Sleep disturbances (SD) are reported to be common in RA but relatively few studies have addressed the issue. We examined the frequency and severity…
Abstract Number: 209 • 2019 ACR/ARP Annual Meeting
Joint Overuse in Patients with Rheumatoid Arthritis
Daisuke Kobayashi¹, Sachimi Amao ², Satoshi Ito ³, Kiyoshi Nakazono ³, Hajime Ishikawa ⁴ and Ichiei Narita ¹, ¹Division of Clinical Nephrology and Rheumatology, Niigata University, Niigata, Niigata, Japan, ²Nursing department, Niigata Rheumatic Center, Shibata, Japan, ³Department of Rheumatology, Niigata Rheumatic Center, Shibata, Japan, ⁴Department of Rheumatology, Niigata Rheumatic Center, Shibata, Niigata, Japan
Background/Purpose: The development of drug therapies for rheumatoid arthritis (RA), and control of synovitis has now become easier. However, once patients are relieved of pain,…
Abstract Number: 210 • 2019 ACR/ARP Annual Meeting
Associations of Clinical Biomarkers with Radiographic Progression of Rheumatoid Arthritis (RA) in African Americans with Early Disease
Emma Astrike-Davis¹, Rebecca Cleveland ¹, Beth Jonas ¹ and Leigh Callahan ¹, ¹Thurston Arthritis Research Center, Chapel Hill, NC
Background/Purpose: To analyze longitudinal data from the Consortium for the Longitudinal Evaluation of African Americans with Early Rheumatoid Arthritis Registry (CLEAR) for the association between…
Abstract Number: 211 • 2019 ACR/ARP Annual Meeting
Effects of Deep Haptic Massage in Fibromyalgia (pilot Study)
aurore FELCE¹, aurore aubrun ¹, yacine allam ¹, Arnaud Choplin ¹, Liana Euller Ziegler ² and Véronique Breuil ³, ¹CHU Nice, nice, France, ²PUPH CHU NICE, nice, France, ³University of Nice, nice, France
Background/Purpose: The management of fibromyalgia is difficult, combining pharmacological and non-drug treatments, including massage. Its pathophysiology, still poorly understood, is complex, including muscle anomalies with…
Abstract Number: 212 • 2019 ACR/ARP Annual Meeting
Utility of Mood Disorders Questionnaire in Fibromyalgia: Data from the Cleveland Clinic Fibromyalgia Registry
Carmen Gota¹, Sahar Kaouk ², Kinanah Yaseen ¹, Nilamba Jhala ¹ and William Wilke ³, ¹Cleveland Clinic, Cleveland, OH, ²University of Dayton, Gates Mills, OH, ³Cleveland Clinic, Richmond Heights, OH
Background/Purpose: Patients with comorbid fibromyalgia syndrome (FMS) and bipolar disorder (BD) were found to have more severe FMS. The Mood disorders questionnaire (MDQ), a self-reported…
Abstract Number: 213 • 2019 ACR/ARP Annual Meeting
Relationship Between a History of Abuse and Fibromyalgia Symptoms and Severity: Data from the Cleveland Clinic Fibromyalgia Registry
Carmen Gota¹, Sahar Kaouk ², Kinanah Yaseen ¹, Nilamba Jhala ¹ and William Wilke ³, ¹Cleveland Clinic, Cleveland, OH, ²University of Dayton, Gates Mills, OH, ³Cleveland Clinic, Richmond Heights, OH
Background/Purpose: It has been proposed that the fibromyalgia syndrome (FMS) phenotype is determined by genetic factors, lack of physical exercise, mood disorders, maladaptive pain responses,…
Abstract Number: 214 • 2019 ACR/ARP Annual Meeting
How Well Do Visual Analogue Scales Used in the Fibromyalgia Impact Questionnaire (FIQ) Correlate with Other Measures of Pain, Fatigue, Sleep, Sleep Disturbance, Anxiety and Depression in Patients with Fibromyalgia
Carmen Gota¹, Sahar Kaouk ², Kinanah Yaseen ¹, Nilamba Jhala ¹ and William Wilke ³, ¹Cleveland Clinic, Cleveland, OH, ²University of Dayton, Gates Mills, OH, ³Cleveland Clinic, Richmond Heights, OH
Background/Purpose: Fibromyalgia syndrome (FMS), is a biopsychosocial condition characterized by widespread pain, fatigue, non-refreshing sleep, and various degrees of anxiety and/or depressive symptoms. Visual analogue…
Abstract Number: 215 • 2019 ACR/ARP Annual Meeting
Opioid Treatment Pattern in a Community Based Rheumatology Clinic
Reema Andrade¹, Paula Roe - Prior ², Oanh Doan ² and Julio Ramos ², ¹The Wright Center For Graduate Medical Education, Crofton, MD, ²The Wright Center For Graduate Medical Education, Scranton, PA
Background/Purpose: Rheumatologic pain, especially fibromyalgia, is difficult to treat. While Nonsteroidal anti-inflammatory drugs (NSAIDs) are traditionally prescribed as the first line treatment for fibromyalgia, when…
Abstract Number: 216 • 2019 ACR/ARP Annual Meeting
Does Fibromyalgia Change the Evaluation of Spondyloarthritis Activity? A Meta-analysis of Observational Studies
Arthur Beck¹, Lilian SOLE ¹, Thomas Barnetche ² and Pascale Vergne-Salle ¹, ¹CHU de LIMOGES, LIMOGES, France, ²CHU de BORDEAUX, BORDEAUX, France
Background/Purpose: Recent studies evaluated the prevalence of Fibromyalgia (FM) in Spondyloarthritis (SpA) and its impact on disease activity scores, but none meta-analysis exists yet. Therefore,…
Abstract Number: 217 • 2019 ACR/ARP Annual Meeting
Fibromyalgia and Multiple Switching of Biologics in Spondylarthritis
Ahmed Negm¹, Nasir Elsidig ¹, Ahlam Al Marzooqi ¹, Noura Zamani ¹, Ayesha Hossaini ¹ and Jamal Al Saleh ¹, ¹Rheumatology Department, Dubai Hospital- Dubai Health Authority, Dubai, Dubai, United Arab Emirates
Background/Purpose: Fibromyalgia (FM) is a condition characterized by chronic widespread pain, tender points, fatigue and disturbed sleep rhythm. Some of these symptoms such as fatigue,…
Abstract Number: 218 • 2019 ACR/ARP Annual Meeting
Effects of Tai Chi versus Aerobic Exercise on Mindfulness in Fibromyalgia
Augustine Lee ¹, Lori Lyn Price ², Raveendhara Bannuru ³ and Chenchen Wang⁴, ¹Department of Physical Medicine and Rehabilitation, Tufts Medical Center, Tufts University School of Medicine, Boston, MA, ²Tufts Medical Center, Tufts University, Boston, MA, ³Tufts Medical Center, Boston, MA, ⁴Tufts Medical Center, Boston
Background/Purpose: Emerging evidence shows that Tai Chi mind–body practice may result in greater benefits in pain and psychological symptoms of Fibromyalgia (FM). Mindfulness is the…
Abstract Number: 219 • 2019 ACR/ARP Annual Meeting
A Fibromyalgia Assessment Screening Tool on a Multidimensional Health Assessment Questionnaire (MDHAQ) Which Does Not Include a Self-Report RADAI Painful Joint Count (RADAI), FAST3nJC, Recognizes Fibromyalgia Similarly to Other FAST3 Indices Which Include a RADAI
Theodore Pincus¹, Isabel Castrejon ² and Joel Block ², ¹Division of Rheumatology, Rush University Medical Center, Chicago, IL, ²Rush University Medical Center, Chicago, IL
Background/Purpose: Fibromyalgia (FM) generally is easily recognized, but a diagnosis may be difficult, particularly in patients with secondary FM who have other primary diagnoses. Criteria…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].